company background image
BAYZ.F logo

Bayer OTCPK:BAYZ.F Stock Report

Last Price

US$30.79

Market Cap

US$30.2b

7D

9.6%

1Y

-50.2%

Updated

27 Mar, 2024

Data

Company Financials +

Bayer Aktiengesellschaft

OTCPK:BAYZ.F Stock Report

Market Cap: US$30.2b

BAYZ.F Stock Overview

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide.

BAYZ.F fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Bayer Aktiengesellschaft Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Bayer
Historical stock prices
Current Share Price€30.79
52 Week High€67.80
52 Week Low€28.00
Beta0.97
1 Month Change-0.84%
3 Month Change-16.71%
1 Year Change-50.18%
3 Year Change-51.46%
5 Year Change-54.69%
Change since IPO-28.20%

Recent News & Updates

Recent updates

Shareholder Returns

BAYZ.FUS PharmaceuticalsUS Market
7D9.6%-0.2%0.6%
1Y-50.2%23.9%29.5%

Return vs Industry: BAYZ.F underperformed the US Pharmaceuticals industry which returned 23.9% over the past year.

Return vs Market: BAYZ.F underperformed the US Market which returned 29.5% over the past year.

Price Volatility

Is BAYZ.F's price volatile compared to industry and market?
BAYZ.F volatility
BAYZ.F Average Weekly Movement4.5%
Pharmaceuticals Industry Average Movement9.5%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: BAYZ.F's share price has been volatile over the past 3 months.

Volatility Over Time: BAYZ.F's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
186396,931Bill Andersonhttps://www.bayer.com

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.

Bayer Aktiengesellschaft Fundamentals Summary

How do Bayer's earnings and revenue compare to its market cap?
BAYZ.F fundamental statistics
Market capUS$30.23b
Earnings (TTM)-US$3.18b
Revenue (TTM)US$51.57b

0.6x

P/S Ratio

-9.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BAYZ.F income statement (TTM)
Revenue€47.64b
Cost of Revenue€19.75b
Gross Profit€27.89b
Other Expenses€30.83b
Earnings-€2.94b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 14, 2024

Earnings per share (EPS)-2.99
Gross Margin58.55%
Net Profit Margin-6.17%
Debt/Equity Ratio132.3%

How did BAYZ.F perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

-4%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.